Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Class Switch Recombination Process in Ataxia Telangiectasia Patients With Elevated Serum Levels of Igm Publisher Pubmed



Mohammadinejad P1 ; Abolhassani H1, 2 ; Aghamohammadi A1 ; Pourhamdi S1 ; Ghosh S3 ; Sadeghi B1 ; Kalmarzi RN1 ; Durandy A4 ; Borkhardt A3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Center for Immunodeficiencies, Children's Medical Center Hospital, Tehran University of Medical Science, Tehran 14194, 62 Qarib St., Keshavarz Blvd., Iran
  2. 2. Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden
  3. 3. Department of Pediatric Oncology, Hematology and Immunology, Heinrich Heine University Medical Center, Dusseldorf, Germany
  4. 4. Inserm U768, Rene Descartes-Paris 5 University and Unit of Pediatric Immunology-Hematology, Necker-Enfants Malades Hospital, Paris, Assistance Publique Hopitaux de Paris, France

Source: Journal of Immunoassay and Immunochemistry Published:2015


Abstract

Ataxia telangiectasia (AT) is a rare primary immunodeficiency disorder with various clinical manifestations. Increased serum levels of IgM and recurrent infections, mainly sinopulmonary infections, can be the presenting feature in a number of AT patients and may be initially misdiagnosed as hyper-IgM (HIgM) syndrome. This study was designed to investigate class switch recombination (CSR) as a critical mechanism in B lymphocytes maturation to produce different isotypes of antibody in response to antigen stimulation in AT cases with HIgM presentation. Quantitative IgE production after stimulation by IL-4 and CD40L was considered as an indicator for CSR function. We also compared their results with sex and age matched AT patients without HIgM presentation. We report four AT patients with recurrent infections during infancy and high serum levels of IgM. Laboratory evaluations revealed defective CSR while none of the three AT patients without HIgM presentation had a defect in the CSR process. The characterized defect in AT is a mutation in the ataxia telangiectasia mutated (ATM) gene. This gene may result in CSR defects due to impaired DNA break repair. A special association between AT and HIgM may indicate a new subgroup of AT patients according to their clinical phenotype and CSR condition. Copyright © Taylor & Francis Group, LLC.
Other Related Docs
12. Respiratory Complications in Patients With Hyper Igm Syndrome, Journal of Clinical Immunology (2019)
18. T-Cell Abnormalities in Common Variable Immunodeficiency, Journal of Investigational Allergology and Clinical Immunology (2016)
24. Primary Antibody Deficiency in a Tertiary Referral Hospital: A 30-Year Experiment, Journal of Investigational Allergology and Clinical Immunology (2015)
29. Monogenic Mutations Associated With Iga Deficiency, Expert Review of Clinical Immunology (2016)
33. Autoimmunity in Primary Antibody Deficiencies, International Archives of Allergy and Immunology (2017)
34. The Heterogeneous Pathogenesis of Selective Immunoglobulin a Deficiency, International Archives of Allergy and Immunology (2019)
41. Primary Immunodeficiencies and Cancers, Cancer Immunology: A Translational Medicine Context (2015)
43. The Clinical and Immunological Features of Patients With Primary Antibody Deficiencies, Endocrine# Metabolic and Immune Disorders - Drug Targets (2018)